http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2325141-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0de3c2a3b6a654048399cc756869a0f3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2006-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b762c309e0795f1203c62bd1ba9585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4352a1e714bcee5a9e1c4dfd44dccf45 |
| publicationDate | 2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2325141-C1 |
| titleOfInvention | Method of initial keratoconus treatment |
| abstract | FIELD: medicine; ophthalmology. n SUBSTANCE: "Bioplast" material is impregnated with immuno-tropic preparation "Super Lymph". A strip of "Bioplast" is inserted projective to the ectasia of the cornea 3 mm away from the limbo through a 2 mm cut in the conjunctive and the Tenon' s capsule. The method can be used to treat keratoconus at early stages by biological activation of the limbo zone of the cornea by "Bioplast" material. The speed of cornea epithelization increases, and the defect in the Bowman's membrane is compensated by better synthesis of glycosaminoglycanes and collagen of IV Type. n EFFECT: prevention of excessive aseptic inflammation and blood flow deficiency in the limbo vessel system. n 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2780273-C1 |
| priorityDate | 2006-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.